Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection

Journal of Infectious Diseases

Volumn 208, Issue 1, 2013, Pages 57-66

  Santos Oliveira, Joanna R ^a   Regis, Eduardo G ^b   Giacoia Gripp, Carmem B W ^a   Valverde, Joanna G ^e   Alexandrino De Oliveira, Priscilla ^f   Lindoso, Jose Ângelo L ^g   Goto, Hiro ^g   Oliveira Neto, Manoel P ^c   Guerra, Jorge O ^h   Grinsztejn, Beatriz ^c   Jerônimo, Selma B ^e   Morgado, Mariza G ^a   Da Cruz, Alda M ^a,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Laboratório de Pesquisa Sobre O Timo   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^f FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h Fundacao de Medicina Tropical Dr Heitor Vieira Dourado   (Brazil)

Author keywords

inflammatory cytokines; microbial translocation; visceral leishmaniasis HIV AIDS coinfection

Indexed keywords

ANTILEISHMANIAL AGENT; ANTIVIRUS AGENT; CD14 ANTIGEN; CD38 ANTIGEN; FATTY ACID BINDING PROTEIN 2; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL TRANSLOCATION; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA EXTRACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOSTIMULATION; INFLAMMATION; LEISHMANIA INFANTUM; MIXED INFECTION; PARASITE LOAD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REMISSION; VIRUS LOAD; VISCERAL LEISHMANIASIS;

INFLAMMATORY CYTOKINES; MICROBIAL TRANSLOCATION; VISCERAL LEISHMANIASIS-HIV/AIDS COINFECTION;

ANTI-HIV AGENTS; ANTIGENS, CD14; COINFECTION; CROSS-SECTIONAL STUDIES; FATTY ACID-BINDING PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEISHMANIASIS, VISCERAL; LIPOPOLYSACCHARIDES; PARASITEMIA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84878611218     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit135     Document Type: Article

References (49)

1. Alvar J, Aparicio P, Aseffa A, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008; 21:334-59.
2. Rabello A, Orsini M, Disch J. Leishmania/HIV co-infection in Brazil: an appraisal. Ann Trop Med Parasitol 2003; 97(Suppl 1):17-28.
3. Sousa-Gomes ML, Maia-Elkhoury AN, Pelissari DM, et al. Co-infection Leishmania/HIV in Brazil: epidemiological, clinical and laboratorial aspects. Epidemiol Serv Saúde 2011; 20:519-26.
4. Wolday D, Akuffo H, Fessahaye G, et al. Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells. Scand J Infect Dis 1998; 30:29-34.
5. Barreto-de-Souza V, Pacheco GJ, Silva AR, et al. Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Infect Dis 2006; 194:846-54.
6. Casado JL, Lopez-Velez R, Pintado V, et al. Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy. Eur J Clin Microbiol Infect Dis 2001; 20:202-5.
7. Cota GF, de Sousa MR, Rabello A. Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review. PLoS Negl Trop Dis 2011; 5:e1153.
8. Zhao C, Papadopoulou B, Tremblay MJ. Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network. Clin Immunol 2004; 113:81-8.
9. Mock DJ, Hollenbaugh JA, Daddacha W, et al. Induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection. PLoS Pathog 2012; 8:e1002635.
10. Bernier R, Barbeau B, Tremblay MJ, et al. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappa B elements. J Immunol 1998; 160:2881-8.
11. Santos-Oliveira JR, Giacoia-Gripp CB, Alexandrino-de-Oliveira P, et al. High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load. BMC Infect Dis 2010; 10:35863.
12. Saha S, Mondal S, Banerjee A, et al. Immune responses in kala-azar. Indian J Med Re 2006; 123:245-66.
13. Goto H, Prianti MG. Immunoactivation and immunopathogeny during active visceral leishmaniasis. Rev Inst Med Trop São Paulo 2009; 51:241-6.
14. Sinha PK, Bimal S, Singh SK, et al. Pre-& post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection. Indian J Med Res 2006; 123:197-202.
15. Alexandrino-de-Oliveira P, Santos-Oliveira JR, Dorval ME, et al. HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-West Brazil. Mem Inst Oswaldo Cruz 2010; 105:692-7.
16. Liu Z, Cumberland WG, Hultin LE, et al. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:83-92.
17. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-70.
18. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214:231-41.
19. Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 2009; 60:471-84.
20. Rodrigues DS, Cunha RM, Kallas EG, et al. Distribution of naive/effector CD4+ T lymphocytes and expression of CD38 on CD8+ T lymphocytes in AIDS patients with tuberculosis. Braz J Infect Dis 2003; 7:161-5.
21. Doisne JM, Urrutia A, Lacabaratz-Porret C, et al. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 2004; 173:2410-8.
22. Gonzalez VD, Falconer K, Blom KG, et al. High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment. J Virol 2009; 83:11407-11.
23. Sandler NG, Koh C, Roque A, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011; 141:1220-30, 1230.e1-3.
24. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71.
25. Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:761-70.
26. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59.
27. Caradonna L, Amati L, Magrone T, et al. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 2000; 6:205-14.
28. Cooke KR, Olkiewicz K, Erickson N, et al. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res 2002; 8:441-8.
29. Lee PI, Ciccone EJ, Read SW, et al. Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. J Infect Dis 2009; 199:1664-70.
30. Baba CS, Makharia GK, Mathur P, et al. Chronic diarrhea and malabsorption caused by Leishmania donovani. Indian J Gastroenterol 2006; 25:309-10.
31. Hicks L, Kant P, Tay PH, et al. Visceral leishmaniasis presenting with intestinal failure: a case report and literature review. Eur J Gastroenterol Hepatol 2009; 21:117-22.
32. Santos-Oliveira JR, Regis EG, Leal CR, et al. Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis. PLoS Negl Trop Dis 2011; 5: e1198.
33. Peruhype-Magalhães V, Martins-Filho OA, Prata A, et al. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral leishmaniasis due to Leishmania chagasi infection. Clin Exp Immunol 2006; 146:124-32.
34. Nylén S, Maurya R, Eidsmo L, et al. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 2007; 204:805-17.
35. Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. Manual de vigilância e controle da leishmaniose visceral. Brasília: Ministério da Sáude, 2006. http://portal.saude.gov.br/portal/ arquivos/pdf/manual-leish-visceral2006.pdf. Accessed November 2012.
36. Brasil, Ministério da Saúde, Departamento de DST, Aids e hepatites virais. Protocolo Clínico e diretrizes Terapêuticas para adultos vivendo com HIV/AIDS. http://www.aids.gov.br/sites/default/files/anexos/ publicacao/2013/52934/-p-vers-atilde-o-preliminar-do-protocolo-cl-iacute-26118. pdf. Accessed April 2013.
37. Weirather JL, Jeronimo SM, Gautam S, et al. Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples. J Clin Microbiol 2011; 49:3892-904.
38. McCoy JJ, Beetham JK, Ochs DE, et al. Regulatory sequences and a novel gene in the msp (GP63) gene cluster of Leishmania chagasi. Mol Biochem Parasitol 1998; 95:251-65.
39. Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010; 6:e1001052.
40. Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012; 30:149-73.
41. Antinori S, Calattini S, Longhi E, et al. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. Clin Infect Dis 2007; 44:1602-10.
42. Lieberman JM, Sacchettini J, Marks C, et al. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 1997; 121:335-42.
43. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005; 3:36-46.
44. Connolly NC, Riddler SA, Rinaldo CR. Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. AIDS Rev 2005; 7:168-80.
45. Medrano FJ, Rey C, Leal M, et al. Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clin Exp Immunol 1998; 114:403-7.
46. Nazli A, Chan O, Dobson-Belaire WN, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010; 6:e1000852.
47. Balkhair A, Ben Abid F. Gastric and cutaneous dissemination of visceral leishmaniasis in a patient with advanced HIV. Int J Infect Dis 2008; 12:111-3.
48. Gómez Senent S, Adan Merino L, Mora Sanz P. Kala azar with gastric involvement. Gastroenterol Hepatol 2009; 32:176-7.
49. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3:791-800.